CLINICAL_TRIALS
trial_result
· 2022-11-03
Clinical Trial Update: Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity [Phase 1]
Summary
Phase 1 trial evaluating bevacizumab for severe retinopathy of prematurity has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jaeb Center for Health Research | Conditions: Retinopathy of Prematurity | Phase 1 | Status: COMPLETED | Results posted: 2022-11-03